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ABSTRACT: Ammonia in the tetrazole Ugi variation
together with α-amino acid methyl ester-derived isocyanides
provides tetrazolopiperidinones in good to high yields in one
pot. The scope and limitations of this reaction were
investigated by performing >70 reactions. The scaﬀold is
useful to ﬁll high-throughput screening decks and in structure-
based drug design.
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■ INTRODUCTION
Diketopiperazine (DKP) is a privileged scaﬀold present in
many natural products as well as in screening libraries of
synthetic compounds (Figure 1).1 While 1,5-disubstituted
tetrazoles are bioisosteric to cis-amides,2 bicyclic tetrazolopiper-
idinones are bioisosteric to DKP, although one amide is
morphed to the tetrazole with the consequence that one less
hydrogen-bond donor and two more hydrogen-bond acceptors
are present (Figure 2). The hydrogen-bond donor−acceptor
count is a key molecular property inﬂuencing oral bioavail-
ability, solubility, stability, and half-life time, just to mention a
few.3
Tetrazolopiperidinones are less prominent in the chemical
literature compared with DKP and can be synthesized by
multicomponent reaction (MCR) pathways (Scheme 1).4−10
MCR-based piperidinone syntheses are very versatile and have
been recently reviewed.11 Previously we described the
successful use of ammonia in the tetrazole Ugi reaction, an
otherwise diﬃcult and low-yielding starting material in other
Ugi variations.12 Here we wish to describe the unprecedented,
straightforward, and versatile synthesis of N-unsubstituted
tetrazolopiperidinones by the Ugi reaction of TMS-N3, α-
amino acid-derived isocyanoacetic acid methyl esters, oxo
components, and ammonia.
■ RESULTS AND DISCUSSION
Ammonia in the Ugi tetrazole reaction often leads to multiple
reaction pathways.13−17 For example, the initially formed
tetrazolomethylamine can react twice further in the Ugi
reaction; ammonia as a strong base can induce aldol-type
condensations with the oxo components; or ammonia can lead
to amidation of the isocyanoacetic acid methyl esters. Not
surprisingly, few successful examples of ammonia Ugi reactions
are known.18−20 Thus, tritylamine as an ammonia surrogate was
introduced in the Ugi MCR.21 In this work, we wanted to
perform the one-pot synthesis of tetrazolopiperidinones C
using a suitable ammonia source in the Ugi tetrazole reaction
and basic reaction conditions for postcyclization. Therefore, it
was not clear a priori whether the envisioned reaction could be
performed successfully. Initially, we selected aqueous ammonia
as the ammonia source and a base to promote the
postcyclization reaction. Not surprisingly, a ﬁrst reaction
using aqueous ammonia in methanol at room temperature
yielded only traces of the product (Table 1). Thus, we
embarked on an extensive optimization exercise to increase the
yield of the reaction by varying the azide and ammonia sources,
temperature, time, solvent, and base.
In order to optimize the reaction conditions, we ﬁrst
screened diﬀerent ammonia sources. Ammonium hydroxide
(1.2 equiv, 28−30 wt % solution of NH3 in water) as an
ammonia source together with cyclohexanone (1 equiv) as an
oxo component, methyl isocyanoacetate (1 equiv), and TMSN3
(1.2 equiv) in methanol (1 M) at room temperature for 18 h
yielded trace amounts of the cyclized product (Table 1, entry
1). Furthermore, the same reaction mixture was heated at 60
°C for 18 h, and we observed a 31% yield of cyclized product
(Table 1, entry 2). Unfortunately, when the reaction was
performed at 60 °C for 18 h without prestirring at room
temperature, no product formation was observed; instead, the
formation of the tetrazole according to Oliveri-Mandala and
Alagna was observed as the major product, (Table 1, entry 3).
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In another attempt, we replaced TMSN3 with sodium azide,
which did not improve the overall yield (Table 1, entry 4).
Furthermore, we envisioned that the use of a base after the Ugi
adduct formation could enhance the cyclization reaction of the
free amino group with the methyl ester group to form the
corresponding tetrazolopiperidinone C. We tested various
bases such as triethylamine, sodium ethoxide, sodium
hydroxide, and sodium hydride, with various solvents and
temperatures (Table 1, entries 5−7). Unfortunately, these
combinations failed to give good yields. Next, we decided to
exchange ammonium hydroxide with ammonium chloride as an
ammonia source. As per our previous experience with α-
aminomethyltetrazole formation, we used a 3:1 methanol/water
mixture as the solvent.8 Thus, we performed the reaction using
ammonium chloride, cyclohexanone, methyl isocyanoacetate,
and sodium azide in 3:1 methanol/water at room temperature
for 18 h, followed by addition of triethylamine and stirring at
room temperature for an additional 18 h. Surprisingly, we
observed a 59% yield of cyclized product (Table 1, entry 8).
Encouraged by these results, we tested the same reaction with
various bases and temperatures (Table 1, entries 9−14). By
using sodium methoxide as a base, we observed hydrolysis of
the methyl ester of the Ugi adduct to form the corresponding
acid as a major side product, and the yield of cyclized product
was lowered to 27% (Table 1, entry 11). A similar observation
was made when ammonium hydroxide was used with
triethylamine (1.0 equiv) as the base. To avoid hydrolysis of
the methyl ester of the Ugi adduct, we decided to use the base
in catalytic amounts (Table 1, entries 13 and 14). Surprisingly,
we observed that the addition of a catalytic amount (0.1 equiv)
of ammonium hydroxide as a base at 50 °C for 18 h gave a
good 67% yield of the cyclized product (Table 1, entry 14).
With these optimized reaction conditions in hand, we looked
into the scope and limitations of the reaction, taking into
account various functional groups (small, bulky, aliphatic,
aromatic, heteroaromatic, cyclic, acyclic, and α,β-unsaturated)
on the oxo components and the isocyanides derived from
methyl esters of α-amino acids; in total, we performed more
than 70 diﬀerent reactions (see Table 2). We purposely
included diﬃcult-to-deactivate starting materials to provide a
realistic scope and limitation study.
Initially, we tested cyclohexanone (1b) with various
isocyanides such as methyl isocyanoacetate and its derivatives
(1a−6a). Reaction of 1b with isocyanide derivatives 2a, 4a, 5a,
and 6a gave excellent yields (26c, 46c, 52c, and 66c,
respectively). With these promising results in hand, we tested
next the reactivity of methyl isocyanoacetate (1a) with various
oxo components such as formaldehyde, p-chlorobenzaldehyde,
3-pentanone, and cyclic ketones such as basic N-benzyl- and
neutral N-Cbz-4-piperidinone. Ketones gave generally good
yields (2c−4c). In the case of aldehydes (Table 2, entries 5 and
6), however, multiple products were observed along with trace
formation of product C, as conﬁrmed by supercritical ﬂuid
chromatography−mass spectrometry (SFC-MS) analysis of the
reaction mixtures. The initial Ugi tetrazole adducts using
aldehydes as the oxo component together with ammonium
chloride were more activated and resulted in an additional Ugi
tetrazole reaction to form the bis(tetrazole) products instead of
Figure 1. DKP fungal natural product brevianamide F (cyan sticks) bound to prenyltransferase (gray sticks) (PDB ID 3O2K).2 Noteworthy is the
fact that the DKP NH undergoes a hydrogen-bond-donor−π interaction (yellow dotted lines) to the Met backbone carbonyl. Hydrogen-bonding,
van der Waals, dipolar, and π−π interactions are shown using red, yellow, cyan, and orange dotted lines, respectively. The stereopicture was rendered
using PYMOL.3
Figure 2. Bioisosterism of diketopiperazine and tetrazolopiperidinone.
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the cyclization with the methyl ester group of the Ugi adduct.
In general, aldehydes gave bis(tetrazoles) as a major product
with ammonia in the Ugi tetrzole reaction.8 Furthermore, we
screened methyl 2-isocyano-2-methylpropanoate (2a) with
diﬀerent oxo components such as cyclic, acyclic, benzylic,
unsaturated, alkyl, aryl, and heteroaryl oxo compounds (Table
2, entries 7−34). Acyclic ketones gave good yields (13c−16c),
whereas α,β-unsaturated ketones gave only traces of the
product (Table 2, entries 17−19). Cyclic ketones such as
cyclohexanone, 4-phenylcyclohexanone, and N-Cbz- and N-
ethoxycarbonyl-4-piperidinone gave excellent yields (26c−
29c). α-Substituted cyclic ketones gave poor yields (24c, 8%;
25c, 14%), likely due to poor reaction in the Ugi adduct
formation as a result of steric hindrance. Product 27c was
isolated as a 9:1 mixture of diastereomers. Interestingly, all of
the cyclic ketones gave spiro-tetrazolopiperidinone compounds.
Benzylic ketones like acetophenone, benzophenone, and their
derivatives failed to give any product; in a few cases, however,
we observed trace formation of product, which was conﬁrmed
by SFC-MS analysis of the reaction mixture. Thus, potentially
Scheme 1. Examples of Previous DKP, Tetrazolylpipridine, and Tetrazolopiperidinone Syntheses and the Present Work
Table 1. Optimization of the Reaction Conditions
entry NH3 source N3 source solvent base (equiv) temp, time yield (%)
1 NH4OH TMSN3 MeOH − RT, 8 h traces
2 NH4OH TMSN3 MeOH − RT, 18 h + 60 °C, 18 h 31
3 NH4OH TMSN3 MeOH − 60 °C, 18 h 48a
4 NH4OH NaN3 MeOH − RT, 18 h + 50 °C, 18 h 35
5 NH4OH TMSN3 MeOH NaOMe (1.0) RT, 18 h + RT, 18 h 22
6 NH4OH NaN3 MeOH NaOMe (1.0) RT, 18 h + 50 °C, 18 h 16
7 NH4OH NaN3 MeOH Et3N (1.0) RT, 18 h + 60 °C, 18 h 9
8 NH4Cl NaN3 MeOH/H2O (3:1) Et3N (1.0) RT, 18 h + RT, 18 h 59
9 NH4Cl NaN3 MeOH/H2O (3:1) Et3N (1.0) RT, 18 h + 60 °C, 18 h 47
10 NH4Cl NaN3 MeOH/H2O (3:1) Et3N (1.0) RT, 18 h + 40 °C, 18 h 50
11 NH4Cl NaN3 MeOH:H2O (3:1) NaOMe (1.0) RT, 18 h + 40 °C, 18 h 27
12 NH4Cl NaN3 MeOH/H2O (3:1) NH4OH (1.0) RT, 18 h + 40 °C, 18 h 29
13 NH4Cl NaN3 MeOH/H2O (3:1) NaOMe (0.1) RT, 18 h + 40 °C, 18 h 55
14 NH4Cl NaN3 MeOH/H2O (3:1) NH4OH (0.1) RT, 18 h + 50 °C, 18 h 67
aThe product was obtained as the free tetrazole.
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Table 2. Substrate Scope and Limitations in the One-Pot Tetrazolopiperidinone Reactiona
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Table 2. continued
aIsolated yields are shown. Diastereomeric ratios (dr) were determined by SFC-MS and 1H NMR analyses. bThe diastereomeric mixture was
isolated in 9:1 dr. cThe cis:trans ratio was 4:1. dThe diastereomeric mixture was isolated in 1:1:0.1:0.1 dr. eThe diastereomeric mixture was isolated
in 4:3 dr. fThe cis:trans ratio was 19:1.
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the product yields could be increased in these cases by
prolonging the reaction time. Similar negative results were
observed with cyclic benzylic ketones such as α-tetralone,
chroman-4-one, and thiochroman-4-one. Similarly, 1,3-dike-
tones such as acetylacetone and 1,3-cyclohexanedione exhibited
the formation of multiple side products along with traces of the
desired tetrazolopiperidinone C. Additionally, we tested
paraformaldehyde, hydrocinnamaldehyde, furfural, phenylglyox-
al, electron-rich 3,4,5-trimethoxybenzaldehyde, and electron-
deﬁcient 4-nitrobenzaldehyde with 2a. We always observed
diﬃculties in puriﬁcation due to formation of multiple side
products along with poor yields of tetrazolopiperidinone
derivatives C. Surprisingly, by using p-chlorobenzaldehyde we
could isolate the required product 12c, but the yield was poor
(22%). Moreover, diﬀerent isocyanides (3a−6a) were
employed and found to be good substrates to obtain
tetrazolopiperidinones C. Methyl 2-isocyano-4-methyl-penta-
noate (3a), for example, gave an excellent yield with acetone
(36c, 75%), while hydroxyacetone gave a 65% yield of cyclized
product (38c) with a diastereomeric ratio of 10:1. The bulky
asymmetric methyl isopropyl ketone gave a moderate yield
(37c, 46%) with a 9:1 diastereomeric ratio. Also, leucine-
derived isocyanide 3a with cyclic ketones like cyclohexanone
(41c, 80%), and N-benzylcyclohexanone (42c, 76%) give
excellent to good yields. Methyl 2-isocyano-2-phenylacetate
(4a) with acyclic and cyclic ketones gave good to excellent
yields (44c−48c). Similarly, the reactions of methyl 2-isocyano-
3-phenylpropanoate (5a) with cyclic ketones resulted in
excellent yields (52c, 53c, 55c, 56c), except with N-
methylpiperidinone (54c, 43%). The acyclic ketone acetone
gave an excellent yield (50c, 79%), and the acyclic asymmetric
ketone ethyl methyl ketone gave the product with a 4:3
diastereomeric ratio in good yield (51c, 65%). The tested
aldehydes performed accordingly with other isocyanides (1a−
6e); furthermore, the reaction of tryptophan-derived isocyanide
6a with cyclic ketones gave excellent yields (66c and 68c),
except for N-methylpiperidinone, which gave a moderate yield
(67c, 41%). Acyclic ketones like acetone (61c, 62%) and 3-
pentanone (62c, 62%) gave moderate yields. Unfortunately,
aldehydes such as hydrocinnamaldehyde and benzaldehyde and
ketones like methyl vinyl ketone, acetophenone, benzophe-
none, α-tetralone, and chroman-4-one failed to produce pure
cyclized product.
In general, acyclic and cyclic ketones, including those with
tertiary amine substituents, are well-tolerated and give good to
excellent yields irrespective of the isocyanide derivative.
Aldehydes gave poor yields, as they formed hyperactive
aminotetrazole derivatives as intermediates, which then react
further with excess aldehyde present in the reaction mixture to
give a second Ugi adduct to form bis(tetrazole) derivatives. α,β-
Unsaturated ketones and benzylic ketones gave trace formation
of product (as conﬁrmed by SFC-MS analysis) irrespective of
the isocyanide derivative used.
Next, we investigated the structures of representative
compounds in the solid state (Figure 3). We were able to
grow crystals of seven products (14c, 16c, 28c, 29c, 46c, 61c,
and 62c) suitable for single-crystal structure determination,
which conﬁrmed the tetrazolopiperidinone scaﬀold design. It is
noteworthy that many diﬀerent hydrogen-bonding motifs
involving the tetrazolopiperidinone could be observed, under-
lining the structural diversity of these diketopiperazine
bioisosteres.
Lipophilicity (expressed as log P) and molecular weight
(MW) are key properties determining the usefulness of
compound series for screening libraries. Ideal molecular weights
are well below 400 Da and lipophilicities should be well below
4. Molecular weight, for example, is a major determinant of
passive membrane diﬀusion and thus oral bioavailability.
Lipophilicity on the other hand determines water solubility
and also metabolic stability. Therefore, we calculated the
Figure 3. Diversity of 3D structures and crystal contacts observed in seven diﬀerent tetrazolopiperidinones (nonpolar hydrogens have been omitted
for clarity; key distances are given in Å). (A) 16c showing the coplanarity of the tetrazole and annulated piperidinone rings. (B) 14c exhibiting a
hydrogen bond between the piperidinone NH and N-5 of a tetrazole moiety of an adjacent molecule. (C) Spiro-29c forming an unsymmetrical
bifurcated hydrogen bond between the piperidinone NH and the N-3 and N-4 of a tetrazole moiety of an adjacent molecule. (D) Symmetrical dimer
interaction involving both amide hydrogen-bond donors and acceptors in spiro-28c. (E) An even shorter dimeric interaction of spiro-46c similar to
that in (D). (F, G) Similar hydrogen-bonding networks of Trp-substructure-containing 61c and 62c involving a piperidinone NH···N-5 tetrazole
motif and a dimeric indole NH···piperidinone O motif.
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theoretical log P values and molecular weights of N-
alkyltetrazolopiperidinones reported earlier7 and our herein-
reported molecules (Figure 4). We found that average
molecular weight of the N-alkyltetrazolopiperidinones reported
by Hulme was 366 and the average log P was 2.35. On the
other hand, our N-unsubstituted tetrazolopiperidinones have a
lower average molecular weight (293) and also a lower log P
value (1.33) compared with the N-alkyltetrazolopiperidinones.
■ CONCLUSIONS
We have described a short, straightforward synthesis of the
tetrazolopiperidinones. Although Hulme and co-workers7
described a similar reaction using primary amines, our method
diﬀers in several key respects: ammonia is a less investigated
reagent in Ugi reactions, previously leading to a lot of side
reactions and only recently leading to useful protocols;8 the
herein-described scaﬀold is represented by a diﬀerent
pharmacophore model and includes one hydrogen-bond
donor but ﬁve hydrogen-bond acceptors; and the average
molecular weight and lipophilicity are much less than the
corresponding N-substituted analogues. Thus, the current
scaﬀold is suitable for compound enrichment of screening
decks, such as the European Lead Factory.22−26
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Dömling, A. Concise Synthesis of Tetrazole−Ketopiperazines by Two
Consecutive Ugi Reactions. Eur. J. Org. Chem. 2015, 2015, 51−55.
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